• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速微流体制备用于靶向药物递送的尼欧索体。

Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery.

机构信息

Institute for Particle Technology (iPAT), Technische Universität Braunschweig, 38104 Braunschweig, Germany.

Centre for Pharmaceutical Engineering Research (PVZ), Technische Universität Braunschweig, 38106 Braunschweig, Germany.

出版信息

Int J Mol Sci. 2019 Sep 22;20(19):4696. doi: 10.3390/ijms20194696.

DOI:10.3390/ijms20194696
PMID:31546717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6801367/
Abstract

Niosomes are non-ionic surfactant-based vesicles with high promise for drug delivery applications. They can be rapidly prepared via microfluidics, allowing their reproducible production without the need of a subsequent size reduction step, by controlled mixing of two miscible phases of an organic (lipids dissolved in alcohol) and an aqueous solution in a microchannel. The control of niosome properties and the implementation of more complex functions, however, thus far are largely unknown for this method. Here we investigate microfluidics-based manufacturing of topotecan (TPT)-loaded polyethylene glycolated niosomes (PEGNIO). The flow rate ratio of the organic and aqueous phases was varied and optimized. Furthermore, the surface of TPT-loaded PEGNIO was modified with a tumor homing and penetrating peptide (tLyp-1). The designed nanoparticular drug delivery system composed of PEGNIO-TPT-tLyp-1 was fabricated for the first time via microfluidics in this study. The physicochemical properties were determined through dynamic light scattering (DLS) and zeta potential analysis. In vitro studies of the obtained formulations were performed on human glioblastoma (U87) cells. The results clearly indicated that tLyp-1-functionalized TPT-loaded niosomes could significantly improve anti-glioma treatment.

摘要

毫微粒是基于非离子表面活性剂的囊泡,在药物传递应用方面有很大的前景。它们可以通过微流控技术快速制备,通过在微通道中控制两种可混溶相(溶解在酒精中的脂质和水溶液)的混合,可以在无需后续的粒径减小步骤的情况下,可重复地生产毫微粒,而无需后续的粒径减小步骤。然而,到目前为止,对于这种方法,毫微粒的性质控制和更复杂功能的实现在很大程度上是未知的。在这里,我们研究了基于微流控技术的拓扑替康(TPT)负载聚乙二醇化毫微粒(PEGNIO)的制造。改变并优化了有机相和水相的流速比。此外,还对载有 TPT 的 PEGNIO 表面进行了肿瘤归巢和穿透肽(tLyp-1)的修饰。本研究首次通过微流控技术设计了由 PEGNIO-TPT-tLyp-1 组成的纳米药物传递系统。通过动态光散射(DLS)和zeta 电位分析确定了其物理化学性质。对获得的制剂进行了体外研究,研究对象为人神经胶质瘤(U87)细胞。结果清楚地表明,tLyp-1 功能化的 TPT 负载毫微粒能够显著改善抗脑胶质瘤治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/ee5f52fb0489/ijms-20-04696-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/ce9895b51b1e/ijms-20-04696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/726cb771e26e/ijms-20-04696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/635c0018159a/ijms-20-04696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/d871c7faf277/ijms-20-04696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/ee5f52fb0489/ijms-20-04696-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/ce9895b51b1e/ijms-20-04696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/726cb771e26e/ijms-20-04696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/635c0018159a/ijms-20-04696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/d871c7faf277/ijms-20-04696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/6801367/ee5f52fb0489/ijms-20-04696-g006.jpg

相似文献

1
Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery.快速微流体制备用于靶向药物递送的尼欧索体。
Int J Mol Sci. 2019 Sep 22;20(19):4696. doi: 10.3390/ijms20194696.
2
Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing.微流控水力聚焦控制单分散类脂体的自组装。
Langmuir. 2010 Jun 1;26(11):8559-66. doi: 10.1021/la904616s.
3
Exploring the potential of silymarin-loaded nanovesicles as an effective drug delivery system for cancer therapy: in vivo, in vitro, and in silico experiments.探讨水飞蓟宾纳米囊泡作为癌症治疗有效药物传递系统的潜力:体内、体外和计算实验。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7017-7036. doi: 10.1007/s00210-024-03099-3. Epub 2024 Apr 17.
4
Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.用于药物递送和生物成像的诊疗一体化脂质体-纳米颗粒杂化物
Int J Mol Sci. 2017 Jul 2;18(7):1415. doi: 10.3390/ijms18071415.
5
In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.含bola-表面活性剂的囊泡用于透皮给药的体外和体内评价
Biomed Microdevices. 2007 Aug;9(4):421-33. doi: 10.1007/s10544-007-9046-6.
6
Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects.非离子型表面活性剂囊泡作为 (+)-儿茶素经皮传递的载体系统及其抗氧化作用。
J Drug Target. 2021 Mar;29(3):310-322. doi: 10.1080/1061186X.2020.1835923. Epub 2020 Oct 27.
7
Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.载姜黄素的尼森体及其在 MCF-7 乳腺癌细胞系中的抗肿瘤活性:一种用于癌症的纳米草药治疗方法。
Daru. 2018 Sep;26(1):11-17. doi: 10.1007/s40199-018-0207-3. Epub 2018 Jul 27.
8
Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.用于经鼻途径脑递送的5-羟色胺受体激动剂盐酸丁螺环酮的脂质体原位鼻腔凝胶的制剂与评价
Pharm Nanotechnol. 2018;6(1):69-78. doi: 10.2174/2211738506666180130105919.
9
Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.用于替米沙坦口服递送的基于脱水山梨醇单硬脂酸酯和胆固醇的脂质体
Curr Drug Deliv. 2018 Feb 14;15(2):260-266. doi: 10.2174/1567201814666170518131934.
10
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.近年来非离子表面活性剂囊泡(niosomes)的研究进展:制备、表征、药物和化妆品应用。
Eur J Pharm Biopharm. 2019 Nov;144:18-39. doi: 10.1016/j.ejpb.2019.08.015. Epub 2019 Aug 22.

引用本文的文献

1
Exploring intracellular anti-mycobacterium activity of lactoferricin-loaded niosomes: proteomics insights into Immunomodulation.探索载乳铁蛋白的非离子型表面活性剂囊泡的细胞内抗分枝杆菌活性:蛋白质组学对免疫调节的见解
Sci Rep. 2025 May 30;15(1):19029. doi: 10.1038/s41598-025-04673-2.
2
Comparative Study of Lycopene-Loaded Niosomes Prepared by Microfluidic and Thin-Film Hydration Techniques for UVB Protection and Anti-Hyperpigmentation Activity.载番茄红素的尼欧索米(niosomes)的比较研究——通过微流控和薄膜水化技术制备,用于 UVB 防护和抗色素沉着活性。
Int J Mol Sci. 2024 Oct 31;25(21):11717. doi: 10.3390/ijms252111717.
3
Nanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing.

本文引用的文献

1
What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.是什么推动创新:加拿大在脂质体疗法方面的特色
Pharmaceutics. 2019 Mar 16;11(3):124. doi: 10.3390/pharmaceutics11030124.
2
Peptide ligand-mediated targeted drug delivery of nanomedicines.肽配体介导的纳米药物靶向药物递送。
Biomater Sci. 2019 Jan 29;7(2):461-471. doi: 10.1039/c8bm01340c.
3
Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy.细胞穿透肽在临床前和临床癌症诊断与治疗中的应用
纳米颗粒载体:CRISPR/Cas9精准基因编辑的新时代。
Microrna. 2024 Oct 31. doi: 10.2174/0122115366319848241022092805.
4
Complex Emulsions as an Innovative Pharmaceutical Dosage form in Addressing the Issues of Multi-Drug Therapy and Polypharmacy Challenges.复合乳剂作为一种创新的药物剂型,用于应对多药治疗和多重用药挑战的问题。
Pharmaceutics. 2024 May 24;16(6):707. doi: 10.3390/pharmaceutics16060707.
5
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.肽搭乘用于神经胶质瘤中纳米系统的发展。
ACS Nano. 2024 Jul 2;18(26):16359-16394. doi: 10.1021/acsnano.4c01790. Epub 2024 Jun 11.
6
Current advances in niosomes applications for drug delivery and cancer treatment.非离子表面活性剂囊泡在药物递送和癌症治疗中的应用现状进展
Mater Today Bio. 2023 Oct 21;23:100837. doi: 10.1016/j.mtbio.2023.100837. eCollection 2023 Dec.
7
Development, Characterization and Pharmacological Evaluation of Cannabidiol-Loaded Long Circulating Niosomes.载大麻二酚的长循环脂质体的研制、表征及药理学评价
Pharmaceutics. 2023 Oct 3;15(10):2414. doi: 10.3390/pharmaceutics15102414.
8
Niosome as an Effective Nanoscale Solution for the Treatment of Microbial Infections.胶束作为一种有效的纳米级解决方案,可用于治疗微生物感染。
Biomed Res Int. 2023 Aug 16;2023:9933283. doi: 10.1155/2023/9933283. eCollection 2023.
9
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles.微流控技术将酶和甾体包封于固体脂质纳米粒中。
Drug Deliv Transl Res. 2024 Jan;14(1):266-279. doi: 10.1007/s13346-023-01398-5. Epub 2023 Jul 28.
10
The impact of solvent selection on the characteristics of niosome nanoparticles prepared by microfluidic mixing.溶剂选择对通过微流控混合制备的囊泡纳米颗粒特性的影响。
Int J Pharm X. 2023 Feb 4;5:100168. doi: 10.1016/j.ijpx.2023.100168. eCollection 2023 Dec.
Oncotarget. 2018 Dec 14;9(98):37252-37267. doi: 10.18632/oncotarget.26442.
4
The penetrating properties of the tumor homing peptide LyP-1 in model lipid membranes.肿瘤归巢肽LyP-1在模型脂质膜中的穿透特性。
J Pept Sci. 2019 Mar;25(3):e3145. doi: 10.1002/psc.3145. Epub 2018 Dec 27.
5
Evaluation of CdTe/CdS/ZnS core/shell/shell quantum dot toxicity on three-dimensional spheroid cultures.CdTe/CdS/ZnS核/壳/壳量子点对三维球体培养物毒性的评估。
Toxicol Res (Camb). 2015 Aug 7;5(1):126-135. doi: 10.1039/c5tx00236b. eCollection 2016 Jan 1.
6
Neuropilin-1 is a glial cell line-derived neurotrophic factor receptor in glioblastoma.神经纤毛蛋白-1是胶质母细胞瘤中一种胶质细胞系源性神经营养因子受体。
Oncotarget. 2017 Jun 27;8(43):74019-74035. doi: 10.18632/oncotarget.18630. eCollection 2017 Sep 26.
7
Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers.载拓扑替康的脂质纳米粒作为治疗皮肤癌的局部治疗的一种可行手段。
J Pharm Pharmacol. 2017 Oct;69(10):1318-1326. doi: 10.1111/jphp.12772. Epub 2017 Jul 13.
8
Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.用于药物递送和生物成像的诊疗一体化脂质体-纳米颗粒杂化物
Int J Mol Sci. 2017 Jul 2;18(7):1415. doi: 10.3390/ijms18071415.
9
Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods.使用不同制造方法制备的单分散非离子表面活性剂囊泡(NISV)的物理特性比较。
Int J Pharm. 2017 Apr 15;521(1-2):54-60. doi: 10.1016/j.ijpharm.2017.02.007. Epub 2017 Feb 3.
10
Controllable synthesis of functional nanoparticles by microfluidic platforms for biomedical applications - a review.用于生物医学应用的微流控平台可控合成功能纳米颗粒——综述
Lab Chip. 2017 Jan 17;17(2):209-226. doi: 10.1039/c6lc01049k.